{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-005456","form_type":"8-K","ticker":"FBLG","cik":"0001958777","company_name":"FibroBiologics, Inc.","filed_at":"2025-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.650058+00:00","generated_at":"2026-05-27T01:05:12.578024+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"FibroBiologics issues shares under $15M SEPA; converts $2.9M note principal","bullets":["Issued 118,991 shares as commitment fee at $2.1010/share on Jan 7, 2025.","Investor converted $900K, $500K, $500K, and $1.1M of Second Note between Jan 23 and Feb 7.","Conversion prices ranged $1.4955 to $1.6301; total shares issued: 1,936,628.","Second Note remaining principal is $2.0M as of Feb 7, 2025.","Sale relied on Section 4(a)(2) exemption; no public offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-005456","json":"https://secwatch.observer/filing/0001493152-25-005456.json","markdown":"https://secwatch.observer/filing/0001493152-25-005456.md","text":"https://secwatch.observer/filing/0001493152-25-005456.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958777/000149315225005456/0001493152-25-005456-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958777/000149315225005456/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T01:05:12.578024+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}